In reports of industry-funded studies that compared the ocular hypotensive efficacy of topical prostaglandins, conclusions in the article abstracts differed from the results of the main outcome measure 62 percent of the time.
Extensive resources are required for its implementation, but there is a strong case that bar-code medication-verification technology should be a required practice for demonstrating "meaningful use" of health information technology under the American Recovery and Reinvestment Act.